If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
David Lenigas, the executive chairman of AfriAg, said: 'We are interested in moving on to AIM or the London Stock Exchange's main market when appropriate..............
In the future US listing maybe? Lets see how this pans out.....DYOR
https://americanmarijuana.org/what-is-sativex/#:~:text=Sativex%20contains%20THC%2C%20which%20is%20the%20psychoactive%20cannabinoid,which%20may%20affect%20mental%20health%20later%20in%20life.
THC that it used m8 in its products...................
Kenny - what is the significance of you posting the wikipedia link of GW Pharmaceuticals to Afri or Apollon? Thanks
MrTHC Andrew posted that this morning m8............
https://total-market-solutions.com/2021/03/apollon/
Just Out.
What deals has he got lined up, who has he been in talks with, more news in pipeline IMHO............
92.56M market cap
RNS
Love hemp..............DYOR
News should be in next 11 market days............
https://www.timeanddate.com/calendar/monthly.html?year=2021&month=3&country=9
The only other company permissioned to use THC in its formulas and have FDA-approved prescription cannabidiol medicine is GW Pharmaceuticals which has been bought by Jazz Pharmaceuticals for $7.2 billion.
DATE
16.03.21
A full spectrum of opportunities for Apollon Formularies
“…Investors will do very well over the next five years if they invest in Apollon…”
With the plethora of cannabis-related listings across UK stock exchanges, the accessibility to consumer CBD and cannabinoid focused companies has increased and investors are holding the likes of Kanabo and Cellular Goods in their ‘green’ portfolios.
It’s less likely they are holding stock in soon-to-be listed Apollon Formularies as the book is already closed after a substantially oversubscribed fundraise.
Head of Business Development Stene Jacobs explains that a lot of capital has already been ‘sunk’ into Apollon so the company didn’t need a huge quantum, but for those who missed out “there is a second round of fundraising that will happen within 2021.”
Apollon is a full spectrum medical cannabis company which makes use of THC in its formulations. That’s the part which makes the consumer high, but more importantly it’s the key component that makes the cannabis medication work.
The only other company permissioned to use THC in its formulas and have FDA-approved prescription cannabidiol medicine is GW Pharmaceuticals which has been bought by Jazz Pharmaceuticals for $7.2 billion.
In addition to its CBD product range, Apollon too includes THC in its medical formulations and has federally approved licences which include its coveted R&D licence which gives it a legal route to conducting physician-supervised human treatments. The company has already done so on close to 500 patients with what Jacobs describes as “phenomenal results.”
Bringing the company to the Aquis Exchange via a reverse takeover is founder and physician Dr. Stephen Barnhill aka ‘The Doc.’ He migrated from producing medicine for big pharma to what at the time was the more niche cannabis treatments that he engaged with when his mother became unwell.
Guiding him through the listing process is Rod McIlree who at the age of 29 years was the youngest person to list a company on the ASX. McIlree has launched multiple companies since then and is currently chairman of Bluejay Mining. (JAY.L)
Listen to Stene talk to Sarah Lowther about the company’s USP’s, how 3D printing will revolutionise medication delivery, its unique-in-the-world R&D licence which allows Apollon to use formulations on patients and the altruism that will be the founder’s swan song and a money maker for investors.
cant be long now surely? everyone is awaiting the next steps and ability to actually, easily trade this share
No mention of AFRI .............. Think he may show more interest once the name change takes place, lets see.
Apollon Formularies
@apollon_uk
·
23m
Developments show that global receptiveness to marijuana is accelerating.
As more countries warm to cannabis, the movement of products into them will be swifter.
https://twitter.com/apollon_uk
If the brokers do move online with Aquis, this will create a lot more interest in the RTO with Apollon. The great news is that you can't short shares on Aquis and they reckon the spreads are much tighter.
Very positive news IMHO.
DL tweet at 7am today: I’m hearing that @AquisStockEx in London may go in to overdrive in the coming weeks as the likes of HL, IG Index and Interactive Investor go live for online trading. Will change the landscape change for AQSE overnight.
Great for Upper Thames #UPPT @ValereumBlkchn @RPoulden
Also known as rick Simpson oil.
Much research is needed on this subject and its benefits but what we do know is full spectrum oil works at many magnitudes of any one singular element, thc, thca , cbd ect..
The entourage effect is staggering.
I suggest anyone who hasn't seen it watch the YouTube vid running from the cure.
I take these things lightly when such bold claims are made but its worth noting that the real rick Simpson never sold a single thing, he took all the risk and gave it all away free to those who suffered in pain from various serious and life threatening illnesses.
This is going to be interesting to watch further research because as if now Israel is the leading contender in medical cannabis research. Its well overdue that other countries forge a path in this field.
Should be in the next 13 market days, did you hear back from Dave L ?
The Company expects that Admission post approval by regulators and shareholders to become effective in March 2021.
On Admission and subject to shareholder and regulatory approval, it is proposed that the Company change its name to Apollon Formularies PLC.
https://www.londonstockexchange.com/news-article/market-news/proposed-rto-re-admission-to-aqse-and-ps2-5m-raise/14874545
When is the admission date ..not long been in from work atb mate